Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope.
about
Structural Characterization of HIV gp41 with the Membrane-proximal External RegionSequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitopeAntigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody ResponsesCharacteristics of the earliest cross-neutralizing antibody response to HIV-1.Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.
P2860
Q27662117-E69D3345-1C92-4B07-9FCA-2BAE92F2636EQ33356323-92FF5AAF-2422-42B6-A622-4ED5B56765AEQ33417195-B8F78DAF-6A50-430D-A847-63723BB120EFQ33529945-A669504E-68FD-44A8-BD57-F41D7F0794EDQ33710195-A79C2568-D097-4138-95A2-F5D9AE39E8C9Q33798076-5B9B3344-AEB9-45C7-8A42-765581972201Q35007412-F18009BF-2857-4081-B66D-8A44346B459AQ37033294-72F97F6D-13FE-4793-8EC2-D8E7BB04741DQ37316019-B1A6039C-B53D-4F7F-832E-7980453B3578Q38405470-484520A1-0D2C-4E4E-9A0A-2F811289DCE7Q38828082-FBADF063-3031-45E0-8615-D05E8371E1FCQ42114702-903F59FB-1874-48C3-BE2A-7C62AC18DD28
P2860
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Assessment of antibody respons ...... om M group consensus envelope.
@en
type
label
Assessment of antibody respons ...... om M group consensus envelope.
@en
prefLabel
Assessment of antibody respons ...... om M group consensus envelope.
@en
P2093
P2860
P1433
P1476
Assessment of antibody respons ...... om M group consensus envelope.
@en
P2093
Adam Penn-Nicholson
Dong P Han
Hanna Park
Michael W Cho
Rais Ansari
Soon J Kim
P2860
P304
P356
10.1016/J.VIROL.2007.11.009
P407
P577
2007-12-19T00:00:00Z